Hoxb4 in oligodendrogenesis
- PMID: 15206819
- PMCID: PMC11529910
- DOI: 10.1023/b:cemn.0000022768.34389.4e
Hoxb4 in oligodendrogenesis
Abstract
1. Although recent advances have provided insight into the transcriptional control of oligodendrocyte (OG) development, little information exists on the role of clustered Hox genes in this process. The aim of this study was to examine the expression profile of Hoxb4 in the oligodendroglial lineage. 2. Immunocytochemical analysis of primary mixed glial cultures demonstrated that Hoxb4 was expressed throughout OG development, being coexpressed with oligodendroglial markers, A2B5, O4 (97%). GalC (91%), and MBP (93%). 3. Immunohistochemical analysis of transverse spinal cord sections demonstrated diffuse expression of Hoxb4 throughout the spinal cord at E12.5 (C16/T19), after which expression was confined primarily to the presumptive gray matter. 4. At E14.25 (C19+/T21), Olig2+ cells had begun to migrate out from the ventral ventricular zone into the presumptive gray matter. These results suggest that Olig2+ cells could coexpress Hoxb4 since it is expressed throughout this region. 5. The expression of Hoxb4 by cells of the OG lineage indicates that it could play a role in OG maturation.
References
-
- Abney, E. R., Williams, B. P., and Raff, M. C. (1983). Tracing the development of oligodendrocytes from precursor cells using monoclonal antibodies, fluorescence-activated cell sorting, and cell culture. Dev. Biol.100:166-171. - PubMed
-
- Armstrong, R. C., Kim, J. G., and Hudson, L. D. (1995). Expression of myelin transcription factor I (MyTI), a “zinc-finger” DNA-binding protein, in developing oligodendrocytes. Glia14:303-321. - PubMed
-
- Asou, H., Hamada, K., Miyazaki, T., Sakota, T., Hayashi, K., Takeda, Y., Marret, S., Delpech, B., Itoh, K., and Uyemura, K. (1995). CNS myelinogenesis in vitro: Time course and pattern of rat oligodendrocyte development. J. Neurosci. Res.40:519-534. - PubMed
-
- Bansal, R., Warrington, A. E., Gard, A. L., Ranscht, B., and Pfeiffer, S. E. (1989). Multiple and novel specificities of monoclonal antibodies O1, O4, and R-mAb used in the analysis of oligodendrocyte development. J. Neurosci. Res.24:548-557. - PubMed
-
- Barres, B. A., Lazar, M. A., and Raff, M. C. (1994). A novel role for thyroid hormone, glucocorticoids and retinoic acid in timing oligodendrocyte development. Development120:1097-1108. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous